ALIMP — Implanet SA Share News
0.000.00%
Last trade - 00:00- €26.60m
- €29.52m
- €12.47m
Brief: Implanet Transfers Its Listing Sponsor Contract To Champeil
Brief: Implanet Announces FDA 510(K) Clearance For Madison Total Knee Prosthesis
Brief: Implanet Granted Patent For JAZZ Lock Implant In Japan
Brief: Implanet Q3 Revenue Up 12% To 1.7 Million Euros
Brief: Implanet H1 Operating Loss Narrows To 1.6 Million Euros
Brief: Implanet Granted Major Patent For Jazz Lock® Implant In US
Brief: Implanet H1 Revenue Up At 3.8 Million Euros
Brief: IMPLANET Announces Booking Of First Orders Supporting Launch Of Partnerships
Brief: Implanet Announces Successful First Jazz Cap Surgeries In U.S.
Brief: Implanet Q1 Revenue Of 1.9 Million Euros
Brief: Implanet FY Total Revenue Down At 6.7 Million Euros
Brief: Implanet Receives FDA Clearance For JAZZ Cap System
Brief: Implanet Considering Various Options For Financing Strategic Plan In April
Brief: Implanet: CE Mark Clearance For Jazz Cap System
Brief: Implanet: Partnership Agreement With Kico Knee Innovation Company
Brief: Implanet Sets Up Bond Financing Line
Brief: Implanet H1 Net Loss Narrows To 2.8 Million Euros
Brief: Implanet SA Implanet Opens German Subsidiary
Brief: Implanet H1 Revenue Down At EUR 3.6 Mln